Rs9679162 genotype predicts prognosis of real-world advanced hepatocellular carcinoma treated by sorafenib

CONCLUSIONS: The GALNT14-rs9679162 "GG" genotype predicted shorter OS in patients with HBsAg-negative aHCC treated with sorafenib, but predicted a favorable response in all patients with aHCC treated with lenvatinib.PMID:36938726 | DOI:10.3233/CBM-220042

Source: Cancer Biomarkers : Section A of Disease Markers - March 20, 2023 Category: Cancer & Oncology Authors: Chih-Lang Lin Rong-Nan Chien Li-Wei Chen Yu-De Chu Chau-Ting Yeh Source Type: research